Answers are grounded in this paper and cite their sources.
Synthetic lethality is a promising cancer therapy strategy that selectively targets tumour cells with defects in DNA repair or cell-cycle regulation. Polynucleotide kinase/phosphatase (PNKP) is a DNA repair enzyme, while Wee1 is a G2/M checkpoint kinase that prevents premature mitotic entry. In previous studies in the Weinfeld lab, it has been hypothesized that the synthetic lethal interaction between PNKP and Wee1 was mediated by mitotic catastrophe. Nevertheless, the mechanism of cell death remains unclear. It was hypothesized that the synthetic lethal interaction between PNKP and Wee1 was mediated by mitotic catastrophe. In this study, wild-type, PNKP knockout, and PNKP-overexpressing HeLa cells were treated with the Wee1 inhibitor MK-1775 to see whether apoptosis or mitotic catastrophe underlies this interaction. Depletion of PNKP in siRNA-transfected cells was confirmed by western blot analysis. Cell death was assessed using PARP1 cleavage by western blotting, DAPI staining, and cell proliferation analysis using time-lapse microscopy. As PARP1 cleavage patterns were variable, apoptosis did not appear as the primary mechanism of cell death, but more research must be done to confirm. However, 500 nM MK1775 led to an increased presence of micronuclei, as seen with DAPI staining in PNKP KO cells. Also, treatment with MK1775 at 500 nM significantly reduced cell proliferation across all cell lines, with a more pronounced effect in KO cells, indicating a threshold-dependent cytotoxic effect. These results support a synthetic lethal interaction between Wee1 and PNKP that may be mediated by mitotic catastrophe. This finding could be beneficial in targeting 1p/19q-codeleted oligodendrogliomas.
No takes yet. Share an insight, caveat, or question.
Sundar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: